Filing Details

Accession Number:
0001104659-22-006584
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-21 20:37:13
Reporting Period:
2022-01-18
Accepted Time:
2022-01-21 20:37:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1554859 Semler Scientific Inc. SMLR Electromedical & Electrotherapeutic Apparatus (3845) 261367393
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1594342 Douglas Murphy-Chutorian C/O Semler Scientific, Inc
2340-2348 Walsh Avenue, Suite 2344
Santa Clara CA 95051
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-18 2,000 $2.10 2,000 No 4 M Direct
Common Stock Disposition 2022-01-18 1,406 $76.48 594 No 4 S Direct
Common Stock Disposition 2022-01-18 594 $77.17 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2022-01-18 2,000 $0.00 2,000 $2.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
83,000 2024-11-08 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 trading plan adopted by the reporting person on December 7, 2021.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.03 to $76.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.05 to $77.405, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.
  4. The shares underlying the option are fully vested and immediately exercisable.